Physician profile
Thomas Klein
NPI 1215195862
$5,986.44
in general payments reported to CMS, 2019-2025
8 companies · $437 in 2025
The $437 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $132 · 2021: $23.26 · 2022: $1,361 · 2024: $3,748 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,765 · Food and Beverage: $1,420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,764.91 |
| Food and Beverage | $1,420.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,999.64 | 2019-2025 | Aveir, Ensite, Jot Dx |
| Boston Scientific Corporation | $2,173.01 | 2024-2025 | Ingevity+, Farapulse |
| Biosense Webster, INC. | $311.01 | 2019-2022 | |
| Medtronic, INC. | $166.32 | 2024 | Cobalt Dr Mri Surescan, Pulseselect, Micra |
| Philips North America LLC | $150.00 | 2022 | |
| Biotronik INC. | $135.90 | 2025 | |
| Cardiva Medical, INC. | $31.50 | 2024 | Ensoetm |
| Ethicon US, LLC | $19.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.